Welcome to Health Link - your quarterly newsletter for HIV/AIDS health technology. We encourage you to read further and learn more about The AIDS Institute's compilation of current HIV/AIDS health technology news.
Josh is a 26 year old gay man in New York City. This is his story:
Talking about HIV is hard... Having HIV is even harder. Talk with all of your sexual partners about HIV. If you don't know your status, get tested. HIV is still a big deal.
A: TeachAIDS is a 501(c)(3) nonprofit social venture that creates breakthrough software addressing numerous persistent problems in HIV and AIDS prevention around the world. Founded at Stanford University, TeachAIDS uses a research-based design process to develop medically-accurate, pedagogically-grounded, and culturally-tailored animated software to optimize learning and retention. Used in more than 30 countries, in partnership with national and international organizations, and incorporating the voices of cultural icons, TeachAIDS provides the most effective HIV and AIDS prevention software to educators, governments, and NGOs around the world – for free.
Approved drugs for HIV treatment: These drug charts include all approved antirretroviral medications for HIV treatment. The charts provide name drug, doses, and important information on side effects (drugs not shown actual size).
The Centers for Disease Control and Prevention recently launched a new web page providing details about the Enhanced Comprehensive HIV Prevention Planning (ECHPP) Project, which is a cornerstone of the larger HHS-wide 12 Cities Project.
PCIP will cover a broad range of health benefits, including primary and specialty care, hospital care, and prescription drugs. All covered benefits are available for you, beginning on your coverage effective date, even if it’s to treat a pre-existing condition - there are no waiting periods.
